Current Courses

Professional Organizations

• Mountain West Society of Toxicology . 01/1996 - present. Position : Member.
• American Society of Pharmacology and Experimental Therapeutics . 01/2001 - present. Position : Member.
• Society of Toxicology . 01/1997 - present. Position : Member.
• International Society for the Study of Xenobiotics . 01/2001 - present. Position : Member.
• Faculty of 1000 Medicine . 01/2010 - present. Position : Associate Member.
• Nano Institute of Utah - Nanobiosensors and Nanomedicine Units . 01/2010 - present. Position : Member.
• University of Utah Center for Genomic Medicine . 01/2019 - present. Position : Member.
• University of Utah Center of Excellence for Exposure Health Informatics (CEEHI). 01/2019 - present. Position : Founding Member and Co-Associate Director of Research.

Courses I Teach

• PHTX 6630 - Pharmacology/Toxicology, Mechanisms of Toxicity
  “Hepatotoxicity; P450 Bioactivation/Reactive Intermediate Toxicities” (2003-2005)
• PHTX 6600 - Pharmacology/Toxicology, Methods in Pharmacology
  “Cloning, Site-directed Mutagenesis and Molecular Toxicology Research” (2003-2012)
• PHTX 7114 - Pharmacology/Toxicology, Principles of Toxicology
  “Metal Toxicity,” “Pesticide Toxicity,” “Toxic Responses of the Skin and Ocular and Visual Systems,” “Mechanisms of Renal Toxicology,” “Reactive Intermediates and Biomolecule Adduct Formation: Identification and Roles in Toxicology.” “Mechanisms of Toxicity: Reactive Intermediates” (2005-2008, 2019-present)
• PHCEU 7010/7960 - Pharmaceutics, Genetic Engineering
  “Recombinant Proteins and Protein Interaction Methods,” “Macromolecular Binding Interactions,” “Genetic Manipulation of Cells and Organisms,” and “Gene Expression Analysis, Microarrays and Cell Culture.” (2007-2011)
• PHARM 5113 - Fundamentals of Pharmaceutical Sciences
  “Mechanisms of Toxicity: Reactive Intermediates and Drug-Drug Interactions” (2011-2014)
• PHTX 7690 - Pharmacology/Toxicology, Professional Skills
  Grant reviewer(2013)
• UUHSC 5600/6600-01 - Inter-professional Education (IPE) Program
  Faculty Facilitator. “Outpatient Stroke Scenario” (1X), “Total Knee Replacement Scenario” (3X). (2014-present)
• PHTX 5221 - Pharmacology II
  “Agents Affecting Ca++ Metabolism” and “Antifungals” (2014-2016), “Newer Antibiotics” (2015-2016), “Treatment of Urinary Tract Infections” (2015-2016), “Anemias” (2016-2017)
• PHTX 5121 - Biomedical Basis of Disease (Pathophysiology)
  “Structure and Function of the Pulmonary System” and “Pulmonary Diseases” (2014-2016)
• PHTX 6710 - Developments in Biochemical Toxicology
  Course Director (2013-2022)
• PHTX 2700 - Common Medicines
  “Antibiotics” (2015-2017)
• Series - PharmD Clinical Seminar
  Facilitator (3 sessions, 2015-2017)
• PHTX 7500 - Biochemical Mechanisms of Signal Transduction
  “TRP Channels: Taste, Temperature, Toxicology, and Therapeutic Targets” (2015-present)
• PHARM 6252 - Integrated Pharmacotherapy
  Pulmonary Structure, Function, and Diseases; Pharmacology of Therapeutics for asthma and COPD (2017-present)
• PHARM 6253 - Integrated Pharmacotherapy II
  Pathophysiology and Treatment of Urinary Tract Infections (2017-2019)
• PHARM 5130/7130 - Foundation of Immunopathology
  “Mechanisms of Toxicity: Reactive Intermediates and Drug-Drug Interactions” (2016-present). “Histamine and Mast Cells” (2017-present) Co-Course Leader 2016, Course Leader 2017-present
• University of Connecticut - Advanced Toxicology course
  Guest Lecturer, Respiratory Toxicology (2020-2022)